Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06229834 · Brigham and Women's Hospital

Chiropractic Care for Episodic Migraine

What this study is about

Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for migraine may be chiropractic care due to the co-occurrence of migraine and musculoskeletal complaints.

View original scientific description

Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for migraine may be chiropractic care due to the co-occurrence of migraine and musculoskeletal complaints. The goal of this application is to perform a pilot study of chiropractic care for episodic migraine to help inform the design of a future, full-scale pragmatic effectiveness trial.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Age 18-65 years
  • Confirmed diagnosis of migraine with or without aura which does not meet criteria for chronic migraine according to the International Classification for -Headache Disorders (ICHD)-3 guidelines at the screening visit with the study physician
  • History of migraines dating for at least one year
  • Completion of at least 26 headache diary days out of 28
  • Confirmed migraine frequency ≥4 to ≤13 days per month during a run-in period
  • If use of medication is applicable, dose must be stable for 2 months prior to study enrollment
  • If use of medication for non-migraine pain condition is applicable (with the exception of episodic tension type headache), dose must be stable for 2 months prior to study enrollment
  • Willing and able to complete all study procedures and be randomized to either of the two intervention groups
  • Fluency in English
  • Confirmed access to and proficiency with use of a smartphone, computer, and/or tablet
  • Working email address or willingness to create an email account for the study

Exclusion criteria

  • Non-Veterans (VAMC only)
  • Received botulinum toxin treatment for headache and/or neck pain within the 4 months prior to the start of the baseline phase
  • Received chiropractic care for any condition within the 3 months prior to the start of the baseline phase
  • Received behavioral interventions (e.g., cognitive behavioral therapy, acceptance and commitment therapy, mindfulness, relaxation techniques, hypnosis) within the past 3 months)
  • Used neuromodulation (i.e., "headache devices"), procedures for migraine prevention within the 2 months before the baseline period, or investigational medications or headache devices for at least 90 days prior to screening
  • Diagnosis of medication overuse headache according to the ICHD-3 guidelines at the screening visit with the study physician
  • Traumatic Brain Injury ≤ 1 year before screening visit or worsening of migraine as noted by the screening study physician
  • Head or neck trauma within the past year causing neurological or musculoskeletal signs or symptoms requiring treatment
  • Any medical, neurologic, or psychiatric condition that the screening study physician deems would lead to difficulty complying with the protocol or negatively impact the safety profile of the interventions
  • Psychiatric hospitalization in the last 6 months
  • Receiving hospice or palliative care
  • History of carotid or vertebral artery dissection
  • Presence of carotid bruits
  • Presence of contraindications (relative or absolute) for spinal manipulation or mobilization where these procedures cannot be modified for safe administration and are consistent with those published by the World Health Organization (WHO) guidelines, including but not limited to:
  • Local spinal hypermobility/instability
  • Conditions causing general spinal hypermobility, such as Marfan, Ehlers-Danlos syndrome, and Osteogenesis imperfecta
  • Malignancy of the spine or spinal cord
  • Frank disc herniation with signs of progressive neurological deficit
  • Spinal or intracanalicular hematomas Inflammatory spondyloarthropathies such as rheumatoid arthritis
  • Spinal fractures or dislocations
  • Avascular necrosis in an area of proposed joint manipulation
  • Bone-weakening disorders affecting the spine, such as benign bone tumors, infection, or osteoporosis
  • Vertebrobasilar insufficiency syndrome
  • Aneurysm involving a major blood vessel in an area of potential joint manipulation
  • History of stroke
  • Anticoagulant therapy or blood disorders cause significant bleeding tendency
  • Cervical spine congenital anomalies that affect the stability or neurologic integrity of the individual or history of cervical spine surgery
  • Either self-reported current alcohol or substance use disorder or current alcohol or substance use disorder documented by a treating medical provider within the past 6 months
  • Hormone replacement therapy for less than six months, or if prescriptions greater than 6 months in duration must be at a stable dose
  • Significant cognitive impairment that would impair participation in the trial
  • Currently pregnant or intention to become pregnant within the next six months

Where

  • Boston, Massachusetts

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jun 26, 2026 · Source of record for eligibility and locations

📊
1 of 60 participants interested
2% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Boston

Massachusetts

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Heart Attack Trials by City

Browse all heart attack clinical trials in these cities — not just this study.

Looking for Episodic Migraine Treatment in Boston?

Join others in Massachusetts exploring innovative treatment options through clinical research

Episodic Migraine Treatment Options in Boston, Massachusetts

If you're searching for Episodic Migraine treatment in Boston, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Boston and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Episodic Migraine. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Massachusetts
Now Enrolling
Up to 60 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Episodic Migraine?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Episodic Migraine

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Episodic Migraine Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06229834. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.